Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 20.45%300.38M | ---- | -33.77%249.39M | ---- | -76.40%376.57M | ---- | 116.04%1.6B | ---- | 0.25%738.69M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -10.10%-23.73M | ---- | -4.45%-21.56M | ---- | 56.73%-20.64M | ---- | -12.28%-47.69M | ---- | 8.71%-42.48M |
| Attributable subsidiary (profit) loss | ---- | 178.86%36.91M | ---- | -156.37%-46.8M | ---- | 82.11%-18.26M | ---- | -510,205.00%-102.06M | ---- | -100.08%-20K |
| Impairment and provisions: | ---- | -93.35%1.19M | ---- | 641.80%17.84M | ---- | -102.58%-3.29M | ---- | -64.87%127.82M | ---- | 111.50%363.87M |
| -Impairmen of inventory (reversal) | ---- | 32.89%-22.43M | ---- | -202.99%-33.42M | ---- | 964.82%32.45M | ---- | -107.66%-3.75M | ---- | -67.25%49M |
| -Impairment of trade receivables (reversal) | ---- | -425.25%-11.4M | ---- | 93.93%-2.17M | ---- | -172.29%-35.74M | ---- | -84.30%49.44M | ---- | --314.87M |
| -Impairment of goodwill | ---- | -34.47%35.01M | ---- | --53.42M | ---- | ---- | ---- | --82.14M | ---- | ---- |
| Revaluation surplus: | ---- | -4,161.49%-13.17M | ---- | 57.84%-309K | ---- | 99.77%-733K | ---- | -1,274.32%-319.54M | ---- | 258.46%27.21M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | 114.08%222K | ---- | -277.19%-1.58M | ---- | -96.93%890K | ---- | 927.23%29.01M |
| -Other fair value changes | ---- | -2,379.85%-13.17M | ---- | -162.91%-531K | ---- | 100.26%844K | ---- | -17,721.69%-320.43M | ---- | -137.72%-1.8M |
| Asset sale loss (gain): | ---- | 36.94%102.09M | ---- | 172.73%74.55M | ---- | -89.30%27.34M | ---- | 21,010.15%255.52M | ---- | -111.69%-1.22M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.82M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 36.94%102.09M | ---- | 172.73%74.55M | ---- | -89.30%27.34M | ---- | 4,462.89%255.52M | ---- | -46.41%5.6M |
| Depreciation and amortization: | ---- | -8.63%1.3B | ---- | -12.60%1.42B | ---- | 15.70%1.62B | ---- | 2.98%1.4B | ---- | 20.32%1.36B |
| Financial expense | ---- | -2.42%380.02M | ---- | 9.84%389.44M | ---- | 3.90%354.56M | ---- | -10.20%341.26M | ---- | -9.33%380.03M |
| Special items | ---- | -191.78%-151.85M | ---- | 69.22%-52.04M | ---- | -49.05%-169.06M | ---- | -55.10%-113.43M | ---- | 3.36%-73.13M |
| Operating profit before the change of operating capital | ---- | -4.98%1.93B | ---- | -6.47%2.03B | ---- | -30.91%2.17B | ---- | 13.99%3.14B | ---- | 15.84%2.76B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 587.50%469.07M | ---- | -113.75%-96.22M | ---- | 399.36%699.83M | ---- | -132.56%-233.78M | ---- | 167.88%718.07M |
| Accounts receivable (increase)decrease | ---- | -645.39%-459.82M | ---- | -82.55%84.31M | ---- | 461.34%483.03M | ---- | 109.26%86.05M | ---- | -213.02%-928.78M |
| Accounts payable increase (decrease) | ---- | 72.52%5.78B | ---- | 102.28%3.35B | ---- | -44.50%1.66B | ---- | 4.25%2.99B | ---- | 162.93%2.86B |
| Derivative financial instruments (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.41%-161K | ---- | -980.44%-27.45M |
| Special items for working capital changes | ---- | 212.53%52.22M | ---- | -33.31%-46.4M | ---- | -114.12%-34.81M | ---- | -20.47%246.46M | ---- | 133.90%309.88M |
| Cash from business operations | ---- | 46.03%7.77B | ---- | 7.01%5.32B | ---- | -20.08%4.98B | ---- | 9.38%6.23B | ---- | 145.81%5.69B |
| Hong Kong profits tax paid | ---- | -103.59%-717K | ---- | 505.96%19.95M | ---- | 51.16%-4.92M | ---- | -114.93%-10.06M | ---- | ---4.68M |
| China income tax paid | ---- | 22.68%-46.4M | ---- | 21.47%-60.02M | ---- | 10.26%-76.43M | ---- | -38.08%-85.17M | ---- | 44.17%-61.68M |
| Other taxs | ---- | 55.22%-455K | ---- | 10.09%-1.02M | ---- | 15.42%-1.13M | ---- | -28.46%-1.34M | ---- | -148.21%-1.04M |
| Special items of business | -9.31%3.64B | ---- | 135.50%4.01B | ---- | -43.19%1.7B | ---- | -18.81%3B | ---- | 202.11%3.7B | ---- |
| Net cash from operations | -9.31%3.64B | 46.26%7.73B | 135.50%4.01B | 7.97%5.28B | -43.19%1.7B | -20.17%4.89B | -18.81%3B | 8.97%6.13B | 202.11%3.7B | 155.12%5.62B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 10.10%23.73M | ---- | 4.45%21.56M | ---- | -56.73%20.64M | ---- | 12.28%47.69M | ---- | -24.74%42.48M |
| Decrease in deposits (increase) | -36.50%34M | -76.47%61.66M | 1,102.36%53.54M | 165.50%262.04M | 101.59%4.45M | -598.05%-400.05M | -383.32%-280.61M | 71.23%-57.31M | 125.65%99.05M | -10,064.54%-199.23M |
| Sale of fixed assets | ---- | -49.83%1.88M | ---- | 4.93%3.75M | ---- | 50.82%3.57M | ---- | -93.16%2.37M | ---- | -17.06%34.65M |
| Purchase of fixed assets | 32.80%-334.7M | -12.28%-574.01M | -145.37%-498.07M | 42.53%-511.25M | 37.14%-202.99M | -66.73%-889.52M | 0.62%-322.91M | 49.14%-533.51M | -22.73%-324.91M | 19.58%-1.05B |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.96%-3.8M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.84M |
| Acquisition of subsidiaries | ---- | -97.56%-1.19B | ---- | 25.91%-601.62M | ---- | -2,003.41%-812M | ---- | ---38.6M | ---- | ---- |
| Recovery of cash from investments | --32.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---7.72M | ---- | ---- |
| Cash on investment | ---- | ---38.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---72.99M |
| Other items in the investment business | 263.79%8.64M | ---- | -126.94%-5.27M | ---- | 111.01%19.57M | --789K | 204.07%9.27M | ---- | -90.95%3.05M | ---- |
| Net cash from investment operations | 42.38%-259.17M | -107.57%-1.71B | -151.33%-449.8M | 60.25%-825.53M | 69.88%-178.96M | -253.71%-2.08B | -166.70%-594.24M | 52.08%-587.08M | 62.55%-222.81M | -20.55%-1.23B |
| Net cash before financing | -5.14%3.38B | 34.91%6.01B | 133.65%3.56B | 58.26%4.46B | -36.59%1.53B | -49.18%2.82B | -30.72%2.41B | 25.98%5.54B | 452.79%3.47B | 270.20%4.4B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 18.08%4.43B | -36.49%4.38B | -25.65%3.75B | 0.07%6.9B | 8.62%5.04B | 1.36%6.89B | 39.02%4.64B | -4.17%6.8B | -46.33%3.34B | -25.52%7.1B |
| Refund | -10.01%-7.2B | 11.28%-9.44B | -10.86%-6.54B | -22.56%-10.64B | 8.81%-5.9B | 19.37%-8.68B | -2.00%-6.47B | -1.67%-10.76B | 2.93%-6.35B | 1.73%-10.59B |
| Interest paid - financing | ---- | 6.79%-366.01M | ---- | -9.92%-392.69M | ---- | -3.48%-357.24M | ---- | 9.13%-345.23M | ---- | 10.11%-379.93M |
| Dividends paid - financing | 0.55%-157.19M | 0.00%-316.11M | 0.00%-158.06M | 3.65%-316.11M | 3.90%-158.06M | -99.48%-328.07M | ---164.46M | ---164.46M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---78.77M | 86.37%-7.65M | ---- | 91.65%-56.14M | ---- | -1,382.73%-672.26M | ---25.56M | ---45.34M | ---- | ---- |
| Other items of the financing business | 19.81%-152.04M | 50.00%-11K | -1.50%-189.59M | ---22K | -6.29%-186.8M | ---- | -3.90%-175.75M | -11,132.45%-752.13M | 11.14%-169.14M | -101.46%-6.7M |
| Net cash from financing operations | -0.77%-3.17B | -27.57%-5.75B | -150.24%-3.15B | -43.24%-4.5B | 44.58%-1.26B | 41.84%-3.14B | 29.91%-2.27B | -37.91%-5.41B | -511.29%-3.24B | -121.79%-3.92B |
| Effect of rate | -486.70%-13.49M | -263.17%-34.04M | 114.83%3.49M | 55.65%-9.37M | -131.23%-23.52M | -155.47%-21.13M | 260.01%75.32M | -27.72%38.1M | -63.50%20.92M | 827.61%52.72M |
| Net Cash | -49.59%210.75M | 666.70%266.89M | 55.88%418.08M | 85.65%-47.1M | 95.42%268.2M | -343.12%-328.18M | -41.84%137.25M | -71.80%134.98M | 139.06%236M | 182.59%478.59M |
| Begining period cash | 29.02%1.04B | -6.58%802.29M | -6.58%802.29M | -28.91%858.76M | -28.91%858.76M | 16.72%1.21B | 16.72%1.21B | 105.48%1.03B | 105.48%1.03B | -53.81%503.68M |
| Cash at the end | 0.70%1.23B | 29.02%1.04B | 10.91%1.22B | -6.58%802.29M | -22.33%1.1B | -28.91%858.76M | 9.96%1.42B | 16.72%1.21B | 95.83%1.29B | 105.48%1.03B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.